← Back to Pharmacy Planet Need other treatments (e.g. inhalers)? Shop the full pharmacy.
Page 4 - Weight Loss
  1. Mounjaro and Wegovy: Why Strength Training Could Be Your Secret Weapon

    Mounjaro and Wegovy: Why Strength Training Could Be Your Secret Weapon

    When you're taking Mounjaro or Wegovy, seeing the number on the scales go down is obviously a big part of the goal.

    But there's another number you might want to pay attention to: how much of that weight is actually fat?

    Losing weight isn't necessarily the same thing as losing body fat. When you're eating fewer calories, some of the weight you lose can come from lean tissue as well as fat.

    This is where strength training can come in.

    Do You Want to Lose Weight or Lose Fat?

    Let's start with the obvious: calories matter.

    To lose weight, you need to use more energy than you consume over time. Mounjaro and Wegovy can make this easier by reducing appetite and helping you feel fuller, which can make it easier to stick to a reduced-calorie diet. The NHS recommends taking these medicines alongside a balanced diet and regular physical activity.

    But there's more to successful weight loss than simply making the number on the scales as small as possible.

    If you're losing a significant amount of weight,

    Read more »
  2. Mounjaro and Wegovy: What Should You Eat When You’re Just Not That Hungry?

    Mounjaro and Wegovy: What Should You Eat When You’re Just Not That Hungry?

    One of the biggest changes people notice when starting Mounjaro or Wegovy is pretty simple: they just aren't as hungry anymore.

    But there is a bit of a catch.

    If your appetite has gone from "I could eat a horse" to "I suppose I should probably eat something", getting enough of the right foods can become a challenge. So, what should you actually eat when you're taking a weight-loss injection and don't feel particularly hungry?

    Don't Use a Smaller Appetite as an Excuse to Stop Eating Properly

    It can be tempting to think that if you're barely hungry, you should simply eat as little as possible. After all, the whole point is to lose weight, right? Not quite.

    Mounjaro and Wegovy are designed to support weight loss alongside a reduced-calorie diet and healthy lifestyle. The NHS still recommends eating a healthy, balanced diet while taking these medicines. The goal isn't to see how little food you can get away with eating. Instead, when your appetite is smaller, the food you do eat becomes even

    Read more »
  3. The Dark Side of Retatrutide: Counterfeit Risks

    The Dark Side of Retatrutide: Counterfeit Risks

    A drug that isn't even approved yet is already being copied and sold on the black market.

    As weight-loss drugs have become increasingly popular, attention has turned towards what could be the next big development: retatrutide. Developed by Eli Lilly, the experimental drug is currently being studied in Phase 3 trials and has already attracted attention from consumers and fitness influencers.

    So how does an average consumer get their hands on a drug that hasn't even been approved yet? It is probably a lot more available than you might think, vials which have become known as 'reta' are being sold around the UK in gyms, beauty salons, hairdressers and even by street florists. If you don't want to make the trip outside, you can even get it delivered after a quick search on social media.

    What Makes Retatrutide Different?

    So what makes retatrutide different from the weight-loss drugs already dominating the market? The answer is that it doesn't target one or two hormonal pathways, it targets three.

    Read more »
  4. Wegovy 7.2 mg Results And Side Effects

    Wegovy 7.2 mg Results And Side Effects: What The Clinical Evidence Shows

    If you are weighing up whether stepping up to Wegovy 7.2 mg is worth it, the honest answer depends on numbers most comparisons gloss over: not just an average weight loss figure, but how many people actually reached meaningful thresholds, and what you trade for that extra effect. Here is what the trial behind this dose actually found.

    What Was The STEP UP Trial, Exactly?

    The STEP UP trial followed 1,407 adults with obesity (BMI 30 or above) who did not have type 2 diabetes. It was a 72-week, randomised, double-blind trial comparing Wegovy 7.2 mg with the standard 2.4 mg dose and placebo.

    Participants were recruited from 95 hospitals, specialist clinics and medical centres across 11 countries. They were randomly assigned to one of the three groups in a 5:1:1 ratio, with all groups also receiving lifestyle support. A separate companion study, STEP UP T2D, looked at the same dose comparison in 512 adults with obesity and type 2 diabetes.

    How Does 7.2 mg Compare With 2.4 mg And Placebo?

    Clearly

    Read more »
  5. Wegovy 7.2 mg

    Wegovy 7.2 mg: What It Is, Who Can Have It And How Stepping Up Works

    Here is the correction that matters most: if you have read elsewhere that Wegovy 7.2 mg is available for a BMI of 27 with a weight-related condition, that is wrong, and it is wrong in a way that could genuinely mislead you about whether you qualify. The real criteria are narrower, and getting this right from the start will save you time.

    What Is Wegovy 7.2 mg, And How Does It Differ From 2.4 mg?

    It is a higher maintenance dose of the same medicine, semaglutide, not a separate product with different effects. 7.2 mg is simply the next step up from the existing 2.4 mg maintenance dose, intended for people who have already completed the full titration schedule and tolerated it well, but have not achieved the weight loss they and their prescriber were aiming for.

    When Was Wegovy 7.2 mg Actually Approved In The UK?

    In two stages, not one. The MHRA approved the 7.2 mg dose on 6 January 2026, given as three 2.4 mg injections taken one after another on the same day, since a dedicated single dose

    Read more »
  6. How Is Foundayo Different from Wegovy Tablets?

    How Is Foundayo Different from Wegovy Tablets?

    Weight loss injections have had quite a lot of attention over the past few years. Now, the tablets would also like a moment.

    Foundayo and Wegovy tablets are both once-daily GLP-1 medicines authorised in the UK for weight management. They work in similar ways, but they are not the same treatment in different packaging.

    They contain different active ingredients, follow different dosing schedules and, perhaps most importantly for your morning routine, have very different instructions around food and drink.

    Let's make the differences a little easier to swallow.

    First Things First: What Are Foundayo and Wegovy Tablets?

    Foundayo is the brand name for orforglipron, a daily GLP-1 tablet developed by Eli Lilly. Wegovy tablets contain semaglutide and are made by Novo Nordisk.

    Both medicines act on GLP-1 receptors involved in appetite. They may help you feel fuller for longer, experience less hunger and manage food cravings, which can make a reduced-calorie diet feel more achievable.

    Both are prescription-only

    Read more »
  7. How Does Foundayo (Orforglipron) Help You Lose Weight?

    How Does Foundayo (Orforglipron) Help You Lose Weight?

    When a new weight-loss tablet arrives, it is reasonable to wonder what it is actually doing.

    Does it burn fat? Speed up your metabolism? Make salad suddenly more appealing than fish and chips?

    Not quite.

    Foundayo, also known by its active ingredient orforglipron, is designed to help manage appetite. In simpler terms, it may make hunger feel a little less demanding.

    Here is how it works.

    What Is Foundayo?

    Foundayo is a prescription-only GLP-1 medicine developed by Eli Lilly. In August 2026, it became the first oral GLP-1 treatment to be authorised in the UK for both weight management and type 2 diabetes.

    Unlike GLP-1 treatments supplied as injections, Foundayo is taken as a tablet once a day. It can be taken at any time of day, without restrictions around food or water.

    For weight management, it is authorised alongside a reduced-calorie diet and increased physical activity for adults with:

    • A BMI of 30 or above; or
    • A BMI between 27 and 30, plus at least one weight-related health condition.
    Read more »
  8. Foundayo or Mounjaro: What Is the Difference?

    Foundayo or Mounjaro: What Is the Difference?

    Foundayo and Mounjaro come from the same pharmaceutical family, but they have taken very different approaches to getting into your system. One arrives as a daily tablet while the other prefers a weekly injection and brings its own pen.

    Both are prescription-only treatments that can support weight management, but they contain different active ingredients, work on different hormone receptors and follow different dosing schedules.

    So, what is the actual difference between them, and does one suit you better?

    What Are Foundayo and Mounjaro?

    Foundayo is the brand name for orforglipron. It is a once-daily GLP-1 tablet authorised in the UK for weight management and insufficiently controlled type 2 diabetes. Mounjaro contains tirzepatide. It is supplied as a pre-filled KwikPen and injected under the skin once a week. It is also authorised in the UK for weight management and type 2 diabetes.

    Both treatments influence appetite, helping you feel fuller, reducing hunger and potentially making food cravings

    Read more »
  9. Can You Lose Muscle While Taking Foundayo?

    Can You Lose Muscle While Taking Foundayo?

    When the scales start moving in the right direction, it is tempting to treat every lost kilogram as good news. After all, that is what you're using the medication for.

    Weight, however, is not made up of just one single part.

    When you lose weight, your body may lose fat, water and some lean tissue. That means the more useful question is not simply, "Am I losing weight?" it's more along the lines of: "What kind of weight am I losing?"

    A Quick Reminder: What Is Foundayo?

    Foundayo is the brand name for orforglipron, a prescription-only GLP-1 medicine developed by Eli Lilly. It was authorised in the UK in August 2026 for weight management and insufficiently controlled type 2 diabetes.

    The tablet is taken once daily and works on areas of the brain involved in appetite. It may help you feel fuller, experience less hunger and manage food cravings, making a reduced-calorie diet easier to follow.

    That can support weight loss. However, the body does not always take all its lost weight neatly from

    Read more »
  10. How Much Weight Could You Lose with Foundayo and How Long Might It Take?

    How Much Weight Could You Lose with Foundayo and How Long Might It Take?

    If you are considering a weight-loss treatment, there is usually one question waiting at the front of the queue:

    How much weight will I actually lose? It is an understandable question. It is also one without a guaranteed personal answer.

    Clinical studies can tell us what happened on average across a large group of people. They cannot look into the future, inspect your bathroom scales and provide an exact number.

    Here is what the research tells us and what it does not.

    A Quick Introduction to Foundayo

    Foundayo is the brand name for orforglipron, a prescription-only GLP-1 medicine developed by Eli Lilly. It was authorised in the UK in August 2026 for weight management and insufficiently controlled type 2 diabetes.

    Unlike several existing GLP-1 treatments, Foundayo is taken as a once-daily tablet rather than an injection. It works by activating GLP-1 receptors involved in appetite. This can help you feel fuller, reduce hunger and manage food cravings, potentially making a reduced-calorie

    Read more »